Stage 4 stomach cancer means the cancer has spread beyond the stomach to distant parts of the body. It is the most advanced stage, and it accounts for roughly 36% of all stomach cancer diagnoses, making it the single most common stage at the time of detection. At this point, treatment focuses on slowing the cancer’s growth, relieving symptoms, and extending life rather than curing the disease.
What “Stage 4” Actually Means
Cancer staging describes how far the disease has traveled from where it started. Stages 1 through 3 mean the tumor is still in or near the stomach, possibly reaching nearby lymph nodes but not distant organs. Stage 4 is defined by one key factor: the cancer has metastasized, meaning it has established new growths in organs or tissues far from the original tumor.
The most common places stomach cancer spreads are the liver (about 48% of patients with metastatic disease), the peritoneum, which is the thin lining of the abdominal cavity (32%), the lungs (15%), and the bones (12%). Some patients have cancer in more than one of these sites at the time of diagnosis.
Why It’s Often Found Late
Stomach cancer tends to grow quietly. Early symptoms like mild indigestion, bloating, or feeling full after small meals overlap with dozens of everyday complaints. By the time more alarming signs appear, such as unintentional weight loss, persistent vomiting, blood in the stool, or severe abdominal pain, the cancer has often already spread.
Even with modern imaging, detecting the full extent of spread can be tricky. CT scans, which are the standard tool for staging, are not great at picking up small deposits on the peritoneum. A minimally invasive procedure called staging laparoscopy, where a small camera is inserted through the abdomen, can detect hidden peritoneal disease that imaging misses. Studies show this procedure finds previously unknown metastatic disease in up to three out of five patients whose scans looked clean.
How Treatment Works at This Stage
Surgery to remove the entire tumor is generally not the goal in stage 4. Instead, treatment is considered “palliative,” meaning it aims to control the cancer, reduce symptoms, and improve quality of life. The backbone of treatment is chemotherapy, often given as a combination of two or three drugs through infusion and sometimes oral tablets. Which combination your oncologist recommends depends heavily on specific characteristics of the tumor itself.
Before starting treatment, the cancer is tested for certain biological markers. Two of the most important are HER2 status and PD-L1 expression. HER2 is a protein that fuels some cancers to grow faster. Roughly 7% to 17% of stomach cancers test positive for high HER2 levels. For those patients, a targeted drug that blocks HER2 is added to chemotherapy, and in March 2025 the FDA granted full approval for combining that targeted drug with an immunotherapy agent for patients whose tumors also express a protein called PD-L1. In one trial, this combination extended the time before the cancer progressed from about 7 months to nearly 11 months.
For tumors that are HER2-negative, the standard approach is chemotherapy combined with immunotherapy drugs that help the immune system recognize and attack cancer cells. Newer targeted options are also available for tumors that express other specific proteins, so biomarker testing at the start is critical to getting the most effective regimen.
What Symptoms to Expect and How They’re Managed
Stage 4 stomach cancer can cause a range of symptoms that shift over time. Some are from the tumor itself pressing on the stomach or blocking it, while others come from the sites where cancer has spread. Common issues include nausea, vomiting, difficulty eating, pain, fatigue, and significant weight loss.
Fluid Buildup in the Abdomen
When cancer spreads to the peritoneum, it can cause a condition called ascites, where fluid accumulates in the abdominal cavity. This creates a swollen, tight feeling in the belly and can make it hard to breathe, eat, or move comfortably. It can also cause swelling in the ankles and legs, constipation, and nausea. Treatment ranges from water pills that help the kidneys flush extra fluid to a procedure called paracentesis, where a needle is used to drain the fluid directly. For patients who need repeated draining, a small catheter can be placed in the abdomen so fluid can be removed at home as needed.
Severe Weight Loss
Cancer-related weight loss, called cachexia, is one of the most common and distressing problems in advanced stomach cancer. It’s not simply a matter of eating too little. The cancer itself changes metabolism, causing the body to break down muscle and fat even when calories are available. A registered dietitian can help with practical strategies: focusing on high-protein, high-calorie, nutrient-dense foods and small frequent meals. Foods naturally rich in omega-3 fats, like salmon, may be beneficial and are generally well tolerated.
Appetite-stimulating medications can offer modest help. Some patients are prescribed short courses of corticosteroids or hormonal drugs that improve appetite and may slow weight loss. Tube feeding or IV nutrition is not routinely recommended for cachexia in advanced cancer because it rarely reverses the underlying metabolic problem, though it may be considered in specific situations like a temporary bowel obstruction.
Survival and What the Numbers Mean
The five-year relative survival rate for stomach cancer that has spread to distant sites is 7.5%, based on data from the National Cancer Institute’s SEER database covering patients diagnosed between 2015 and 2021. That number means that, compared to the general population, about 7 to 8 out of 100 people with distant-stage stomach cancer were alive five years after diagnosis.
It’s important to understand what this number doesn’t capture. It reflects outcomes from patients treated years ago, and treatment has evolved meaningfully since then, with newer immunotherapy and targeted therapy combinations becoming available. Individual prognosis varies widely depending on where the cancer has spread, how the tumor responds to treatment, the patient’s overall health, and the tumor’s biological profile. Someone whose cancer responds well to a first-line regimen may live considerably longer than the statistical average suggests.
Biomarker Testing Shapes Your Options
One of the most important steps after a stage 4 diagnosis is comprehensive biomarker testing of the tumor tissue. This is not optional or experimental; it directly determines which treatments are available to you. At minimum, your tumor should be tested for HER2 overexpression, PD-L1 expression level, and a feature called microsatellite instability, which indicates whether certain immunotherapy drugs are likely to work. Some tumors are also tested for a protein called CLDN18.2, which opens the door to a newer targeted therapy.
About 85% of patients with HER2-positive stomach cancer also have tumors that express PD-L1 at levels that qualify them for the newest approved combination regimen. If your oncology team has not discussed biomarker results with you, it’s worth asking specifically what was tested and what the results mean for your treatment plan.